Skip to main content
Clinical Trials/CTRI/2024/06/069439
CTRI/2024/06/069439
Not yet recruiting
Phase 3

Discharge Time And Satisfaction Score Of Patients Undergoing Endoscopies Under Intravenous Remifentanil Sedation - A Prospective Observational Study - Nil

Regional cancer centre,Trivandrum0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: 8- Other Procedures
Sponsor
Regional cancer centre,Trivandrum
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Regional cancer centre,Trivandrum

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 75 years
  • Both males and females
  • ASA 1 and 2

Exclusion Criteria

  • Age less than 18 and more than 75 years
  • ASA 3 and above
  • Allergic to any opioids

Outcomes

Primary Outcomes

Not specified

Similar Trials